Related Experiment Videos
[Pancreas and islet transplantations]
1Second Department of Surgery, Faculty of Medicine, University of Tokyo, Japan.
Nihon Geka Gakkai Zasshi
|November 1, 1996
Summary
Pancreas transplantation offers a viable treatment for type 1 diabetes, with successful patient survival rates. Advances in immunosuppression and diagnostics are key to improving outcomes for pancreas and islet transplantation.
Area of Science:
- Transplantation immunology and endocrinology.
- Surgical techniques and post-operative care in organ transplantation.
Context:
- Type 1 diabetes mellitus management.
- Established pancreas transplantation protocols and outcomes.
- Emerging islet and xenotransplantation strategies.
Purpose:
- To review the current status and challenges of pancreas transplantation.
- To discuss advancements in immunosuppression and diagnostic methods for acute rejection.
- To explore the potential of islet and xenotransplantation for diabetes treatment.
Summary:
- Pancreas transplantation demonstrates significant patient survival (91%) and graft survival (71%) at one year.
- Simultaneous pancreas-kidney transplantation with bladder drainage facilitates early acute rejection diagnosis.
- Current immunosuppression involves multiple agents, with FK506 showing promise; islet transplantation requires further development.
Impact:
- Improved therapeutic options for type 1 diabetes mellitus patients.
- Potential for enhanced graft survival through advanced immunosuppressive regimens and diagnostic tools.
- Future directions in transplantation research, including islet and xenotransplantation, offer hope for more effective diabetes management.